Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring

Aim. The objective of this study was to evaluate the efficacy of diabetic macular edema (DME) therapy using subthreshold micropulse laser (SMPL) with a wavelength of 577 nm during a long-term monitoring period of 5 years. Methods. The cohort included the total number of 52 eyes of 34 patients with D...

Full description

Bibliographic Details
Main Authors: Martina Zavorkova, Jana Nekolova, Lidmila Prochazkova, Eva Cermakova, Nada Jiraskova
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2023-03-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-202301-0011_diabetic-macular-edema-treatment-with-subthreshold-micropulse-laser-five-year-long-monitoring.php
_version_ 1797835511420682240
author Martina Zavorkova
Jana Nekolova
Lidmila Prochazkova
Eva Cermakova
Nada Jiraskova
author_facet Martina Zavorkova
Jana Nekolova
Lidmila Prochazkova
Eva Cermakova
Nada Jiraskova
author_sort Martina Zavorkova
collection DOAJ
description Aim. The objective of this study was to evaluate the efficacy of diabetic macular edema (DME) therapy using subthreshold micropulse laser (SMPL) with a wavelength of 577 nm during a long-term monitoring period of 5 years. Methods. The cohort included the total number of 52 eyes of 34 patients with DME. All underwent the standard laser treatment for the diabetic retinopathy outside the macula and DME treatment with SMPL. Subsequent check-ups were followed every 3 months in the first year of treatment, and every 4 to 6 months in the following years. The treatment was combined neither with focal macular laser nor with anti-VEGF therapy. Results. The mean central retinal thickness (CRT) was 345.9 µm SD 122.6 µm at the beginning of the monitoring. At the end of the follow-up period five years after treatment it was 256.4 µm SD 98.4 µm. The mean CRT decreased by 89.5 µm SD 153.6 µm during 5 years. At the beginning of the monitoring, before treatment with SMPL, the best corrected visual acuity (BCVA) was 70.0, SD 10.1 ETDRS letters. One year after therapy, BCVA was 72, SD 10.0 letters, two years later it was 71.4, SD 10.4 letters and decreased to 66.9, SD 12.1 letters after 5 years. The mean BCVA decreased by merely 3.1, SD 10.9 letters during 5 years. Conclusion. Based on our long-term observations, the DME treatment with SMPL appears to be an effective method for reducing DME and protecting BCVA against rapid worsening.
first_indexed 2024-04-09T14:53:52Z
format Article
id doaj.art-25ae73adfcfb4b5d91e897670a2f8a63
institution Directory Open Access Journal
issn 1213-8118
1804-7521
language English
last_indexed 2024-04-09T14:53:52Z
publishDate 2023-03-01
publisher Palacký University Olomouc, Faculty of Medicine and Dentistry
record_format Article
series Biomedical Papers
spelling doaj.art-25ae73adfcfb4b5d91e897670a2f8a632023-05-02T08:04:03ZengPalacký University Olomouc, Faculty of Medicine and DentistryBiomedical Papers1213-81181804-75212023-03-011671747910.5507/bp.2022.055bio-202301-0011Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoringMartina Zavorkova0Jana Nekolova1Lidmila Prochazkova2Eva Cermakova3Nada Jiraskova4Department of Ophthalmology, Faculty of Health Studies, Jan Evangelista Purkyne University and Department of Ophthalmology, Masaryk Hospital, Usti nad Labem, Krajska zdravotni a.s., Usti nad Labem, Czech RepublicDepartment of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University and Department of Ophthalmology, University Hospital Hradec Kralove, Czech RepublicDepartment of Ophthalmology, Faculty of Health Studies, Jan Evangelista Purkyne University and Department of Ophthalmology, Masaryk Hospital, Usti nad Labem, Krajska zdravotni a.s., Usti nad Labem, Czech RepublicDepartment of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech RepublicDepartment of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University and Department of Ophthalmology, University Hospital Hradec Kralove, Czech RepublicAim. The objective of this study was to evaluate the efficacy of diabetic macular edema (DME) therapy using subthreshold micropulse laser (SMPL) with a wavelength of 577 nm during a long-term monitoring period of 5 years. Methods. The cohort included the total number of 52 eyes of 34 patients with DME. All underwent the standard laser treatment for the diabetic retinopathy outside the macula and DME treatment with SMPL. Subsequent check-ups were followed every 3 months in the first year of treatment, and every 4 to 6 months in the following years. The treatment was combined neither with focal macular laser nor with anti-VEGF therapy. Results. The mean central retinal thickness (CRT) was 345.9 µm SD 122.6 µm at the beginning of the monitoring. At the end of the follow-up period five years after treatment it was 256.4 µm SD 98.4 µm. The mean CRT decreased by 89.5 µm SD 153.6 µm during 5 years. At the beginning of the monitoring, before treatment with SMPL, the best corrected visual acuity (BCVA) was 70.0, SD 10.1 ETDRS letters. One year after therapy, BCVA was 72, SD 10.0 letters, two years later it was 71.4, SD 10.4 letters and decreased to 66.9, SD 12.1 letters after 5 years. The mean BCVA decreased by merely 3.1, SD 10.9 letters during 5 years. Conclusion. Based on our long-term observations, the DME treatment with SMPL appears to be an effective method for reducing DME and protecting BCVA against rapid worsening.https://biomed.papers.upol.cz/artkey/bio-202301-0011_diabetic-macular-edema-treatment-with-subthreshold-micropulse-laser-five-year-long-monitoring.phpdiabetic macular edemasubthreshold micropulse laser therapy
spellingShingle Martina Zavorkova
Jana Nekolova
Lidmila Prochazkova
Eva Cermakova
Nada Jiraskova
Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring
Biomedical Papers
diabetic macular edema
subthreshold micropulse laser therapy
title Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring
title_full Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring
title_fullStr Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring
title_full_unstemmed Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring
title_short Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring
title_sort diabetic macular edema treatment with subthreshold micropulse laser five year long monitoring
topic diabetic macular edema
subthreshold micropulse laser therapy
url https://biomed.papers.upol.cz/artkey/bio-202301-0011_diabetic-macular-edema-treatment-with-subthreshold-micropulse-laser-five-year-long-monitoring.php
work_keys_str_mv AT martinazavorkova diabeticmacularedematreatmentwithsubthresholdmicropulselaserfiveyearlongmonitoring
AT jananekolova diabeticmacularedematreatmentwithsubthresholdmicropulselaserfiveyearlongmonitoring
AT lidmilaprochazkova diabeticmacularedematreatmentwithsubthresholdmicropulselaserfiveyearlongmonitoring
AT evacermakova diabeticmacularedematreatmentwithsubthresholdmicropulselaserfiveyearlongmonitoring
AT nadajiraskova diabeticmacularedematreatmentwithsubthresholdmicropulselaserfiveyearlongmonitoring